Reuters logo
BRIEF-Cara Therapeutics resumes patient recruitment
2016年6月6日 / 上午11点12分 / 1 年前

BRIEF-Cara Therapeutics resumes patient recruitment

June 6 (Reuters) - Cara Therapeutics Inc :

* Resumed patient recruitment after FDA removed clinical hold on CLIN3001 adaptive phase 3 trial of I.V. CR845 for postoperative pain

* Study will continue as a three-arm trial comparing two doses of CR845 (1.0 and 0.5 ug/kg) to placebo

* To provide updates on progress of trial later this year

* Cara Therapeutics resumes patient recruitment for adaptive phase 3 trial of I.V. CR845 in postoperative pain Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below